Patent Yard Sign in
Canadian application, no grantCanada

Compounds for the treatment of female sexual dysfunction

CA 2323183 A1 · Owner: Maw, Graham Nigel · Inventors: Maw, Graham Nigel; Wayman, Christopher Peter

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A method of treating a female suffering from FSD in particular FSAD, is , described, The method comprises delivering to the female an agent that is capable of potentiating cAMP in the sexual genitalia; wherein the agent is in an amount to cause, potentiation of cAMP in the sexual genitalia of the female. The agent may be admixed with a pharmaceutically acceptable carrier diluent or excipient. Said , agent, is an inhibitor of NEP (I:NEP).

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed November 7, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 7, 2020.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 7, 2022.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledNovember 7, 2000
GrantedNo grant recorded
Term endedNovember 7, 2020
Patent numberCA 2323183 A1
Classification (IPC)A61K31/19 +2 more

Timeline

Timeline From CIPO dates

2001200320052007200920112013201520172019Application filedNov 7, 2000Term endedNov 7, 2020

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.